SCHEMBL7956017

SCHEMBL7956017

CC(C)Oc1cccc(CC(=O)Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX3 P56373 1/20 0.48
POLB P06746 1/20 0.47
KDM4E B2RXH2 2/20 0.47
NSD2 O96028 1/20 0.47
ALDH1A1 P00352 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
RXRA P19793 1/20 0.45
RXRB P28702 1/20 0.45
CNR2 P34972 1/20 0.44
FFAR4 Q5NUL3 3/20 0.44
DHFR P00374 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CTBP2 P56545 1/20 0.43
GAA P10253 1/20 0.43
HTT P42858 1/20 0.43
HSD17B10 Q99714 1/20 0.43
HCRTR1 O43613 1/20 0.43
HCRTR2 O43614 1/20 0.43
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10920750 0.87 ALDH1A1 (0.41) P2RX3POLBALDH1A1SMN1; SMN2DHFR
SCHEMBL5743613 0.85 FFAR4 (0.51) POLBKDM4ENSD2ALDH1A1SMN1; SMN2
SCHEMBL1416873 0.85 POLB (0.67) P2RX3POLBKDM4ENSD2ALDH1A1
SCHEMBL5394435 0.83 CYP3A4 (0.54) KDM4EALDH1A1CNR2MEN1KMT2A
SCHEMBL211498 0.83 CTBP2 (0.60) POLBALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL10921397 0.83 FAAH (0.47) ALDH1A1MEN1KMT2AHTT
SCHEMBL7956391 0.82 TSHR (0.65) P2RX3POLBKDM4ENSD2ALDH1A1
SCHEMBL7898755 0.81 FAAH (0.46) POLBKDM4EALDH1A1SMN1; SMN2FFAR4
SCHEMBL3944254 0.81 POLB (0.71) P2RX3POLBKDM4EALDH1A1CNR2
SCHEMBL6210356 0.81 CNR2 (0.52) P2RX3POLBKDM4ENSD2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1081635-C Substituted pyrrolidin-3-Yl-alkyl-piperidines useful as tachykinin antagonists MERRELL DOW PHARMA (US) 2002-03-27 CN disclosed
US-6329392-B1 ANTIALLERGENS AVENTIS PHARMACEUTICALS, INC. 2001-12-11 US disclosed
EP-0777666-B1 SUBSTITUTED PIPERIDINES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES MERRELL PHARMA INC (US) 1999-03-03 EP disclosed
US-5861416-A TREATMENT OF ASTHMA OR COUGH MERRELL PHARMACEUTICALS INC. (US) 1999-01-19 US disclosed
US-5824690-A TREATING ASTHMA, COUGH HOECHST MARION ROUSSEL INC. (US) 1998-10-20 US disclosed
US-5661160-A ADMINISTERING AN ANTITUSSIVE AGENT FOR TREATING COUGH; TACHYKININ ANTAGONISM, SUBSTANCE P AND NEUROKININ A ANTAGONISM MERRELL PHARMACEUTICALS INC. (US) 1997-08-26 US disclosed
US-5648366-A TACHYKININ ANTAGONISTS USEFUL IN TREATING ASTHMA MERRELL PHARMACEUTICALS INC. (US) 1997-07-15 US disclosed
EP-0777666-A1 NOVEL SUBSTITUTED PIPERIDINES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES MERRELL PHARMACEUTICALS INC. (US) 1997-06-11 EP disclosed
US-5635510-A TACHYKININ (ESPECIALLY SUBSTANCE P AND NEUROKININ A) ANTAGONISTS; ANTIINFLAMMATORY AGENTS, ANALGESICS; NERVOUS SYSTEM DISORDERS; BRONCHODILATOR AGENTS MERRELL PHARMACEUTICALS INC. (US) 1997-06-03 US disclosed
CN-1124961-A Substituted pyrrolidin-3-Yl-alkyl-piperidines useful as tachykinin antagonists MERRELL DOW PHARMA (US) 1996-06-19 CN disclosed
WO-1996006094-A1 NOVEL SUBSTITUTED PIPERIDINES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES MERRELL PHARMACEUTICALS INC. (US) 1996-02-29 WO disclosed